Vassilios Myrianthopoulos

Structural Basis for the Synthesis of Indirubins as Potent and Selective Inhibitors of Glycogen Synthase Kinase-3 and Cyclin-Dependent Kinases

Panagiotis Polychronopoulos, Prokopios Magiatis, Alexios‐Léandros Skaltsounis et al. · Journal of Medicinal Chemistry · 2004 · 375 citations · Full text

Roscovitine-Derived, Dual-Specificity Inhibitors of Cyclin-Dependent Kinases and Casein Kinases 1

Nassima Oumata, Karima Bettayeb, Yoan Ferandin et al. · Journal of Medicinal Chemistry · 2008 · 135 citations · Full text

Soluble 3′,6-Substituted Indirubins with Enhanced Selectivity toward Glycogen Synthase Kinase -3 Alter Circadian Period

Konstantina Vougogiannopoulou, Yoan Ferandin, Karima Bettayeb et al. · Journal of Medicinal Chemistry · 2008 · 116 citations · Full text

6-Br-5methylindirubin-3′oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: Exploitation of GSK-3 for treating leishmaniasis

Evangelia Xingi, Despina Smirlis, Vassilios Myrianthopoulos et al. · International Journal for Parasitology · 2009 · 74 citations

Induces Apoptosis-like Death, Necroptosis, Apoptosis +9

Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer

Nadiya Druzhyna, Bartosz Szczęsny, Gábor Oláh et al. · Pharmacological Research · 2016 · 74 citations · Full text

Experimental Therapy, Medicine, Rational Drug Design +10